| 書目名稱 | Cardiac Arrhythmias: New Therapeutic Drugs and Devices |
| 副標(biāo)題 | Proceedings of the S |
| 編輯 | Joel Morganroth,E. Neil Moore |
| 視頻video | http://file.papertrans.cn/222/221729/221729.mp4 |
| 叢書名稱 | Developments in Cardiovascular Medicine |
| 圖書封面 |  |
| 描述 | In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon precisely what question is being asked. The large number of experimental models used to evaluate antiarrhythmic compounds points out the inability of anyone model to define the probability of antiarrhythmic efficacy in man. It has therefore become standard practice to utilize a batter of animal models for the evaluation of new antiarrhythmic agents. Each model has its own advantages and disadvantages and it is necessary to understand each model fully in oder to evaluate experimental findings and apply them to clinical settings. We believe that the availability of the chronic myocardial infarction ventricular tachyarrhythmia model provides 1) an excellent opportunity to more precisely understand arrhythmia mechanisms, 2) to develop new techniques such as signal averaging for evaluating late low level potentials identifying hearts at high risk of sudden death 3) to identify new antifibrillatory drugs versus drugs that are effective primarily against PVC‘s and ventricular tachycardia 4) to identify new surgical techniques to eliminate V |
| 出版日期 | Conference proceedings 1985 |
| 關(guān)鍵詞 | arrhythmia; drug; drugs; heart; heart disease; myocardial infarction; research; sudden cardiac death |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-1-4613-2595-6 |
| isbn_softcover | 978-1-4612-9626-3 |
| isbn_ebook | 978-1-4613-2595-6Series ISSN 0166-9842 |
| issn_series | 0166-9842 |
| copyright | Martinus Nijhoff Publishing, Boston 1985 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2026-1-25 07:01
發(fā)表于 2025-3-21 16:39:43
